Carefusion 2200 Inc recalls JAMSHIDI NEEDLE BIOPSY [15G X 100MM DISP, 16G X 100MM DISP, 17G X 100MM, 16G X 70MM DISP]; STERILE;
- Recall date
- February 23, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-1422-2018
- FDA classification
- Class II
- Brand / firm
- Carefusion 2200 Inc
- Sold / distributed
- Nationwide, Australia, Brazil, Canada, China, Japan, Kuwait, Malaysia, Mexico, Netherlands, New Zealand, Philippines, Singapore, South Africa, Taiwan, Thailand, United Arab Emirates, Vietnam
Why it was recalled
The integrity of the sterile packaging is potentially compromised.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
JAMSHIDI NEEDLE BIOPSY [15G X 100MM DISP, 16G X 100MM DISP, 17G X 100MM, 16G X 70MM DISP]; STERILE;
Get recall alerts
Free email alert whenever Carefusion 2200 Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Carefusion 2200 Inc